I was a former shareholder that sold out on the recent poor share price performance.

• Terri is a CEO that comes across as frank and business focused and doesn't shy away from the tough questions
• Terri has that sweet spot between medical and industry background to be able to articulate medical issues clearly and succinctly
• Leveraging and unlocking additional revenue streams - using their imaging dataset as a base to unlock new medical insights > now a 'goldmine'

I will definitely be looking to buy back into VHT over the next couple of days (IRL and Strawman), it's given me confidence to back the Volpara vision again.

Thanks @Strawman for organising!

More likely downward pressure on the share price after removal from S&P/ASX All Technology Index (Effective Prior to the Open on June 20, 2022)

Edit: typo